5 Results for "

Talarozole

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "Talarozole" in MCE Product Catalog:

22
22 Cited Publications
Cat. No.: HY-14531
CAS No.: 201410-53-9
Purity:  99.61%
Synonyms: R115866
Research Areas:  

Inflammation/Immunology

Talarozole (R115866) is an oral systemic all-trans retinoic acid metabolism blocking agent (RAMBA) which increases intracellular levels of endogenous all-trans retinoic acid (RA). Talarozole inhibits both CYP26A1 and CYP26B1 with IC50s of 5.4 and 0.46 nM, respectively.
loading...
    loading...
Cat. No.: HY-14802C
CAS No.: 201410-66-4
Purity:  99.28%
Target:  

RAR/RXR Autophagy

Research Areas:  

Cancer

(+)-Talarozole is a potent inhibitor of retinoic acid metabolism extracted from patent WO 1997049704 A1.
loading...
    loading...
Cat. No.: HY-14802D
CAS No.: 201410-67-5
Purity:  98.12%
Target:  

RAR/RXR Autophagy

Research Areas:  

Cancer

(-)-Talarozole is a potent inhibitor of retinoic acid metabolism extracted from patent WO 1997049704 A1.
loading...
    loading...
Cat. No.: HY-14802
CAS No.: 870093-23-5
Synonyms: (R)-Talarozole
Target:  

Cytochrome P450

Research Areas:  

Cancer

Talarozole R enantiomer is a potent and selective inhibitor of cytochrome P450 26-mediated breakdown of endogenous all-trans retinoic acid for the treatment of psoriasis and acne.
loading...
    loading...
Cat. No.: HY-14531R
CAS No.: 201410-53-9
Synonyms: R115866 (Standard)
Talarozole (Standard) is the analytical standard of Talarozole. This product is intended for research and analytical applications. Talarozole (R115866) is an oral systemic all-trans retinoic acid metabolism blocking agent (RAMBA) which increases intracellular levels of endogenous all-trans retinoic acid (RA). Talarozole inhibits both CYP26A1 and CYP26B1 with IC50s of 5.4 and 0.46 nM, respectively.
loading...
    loading...